The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Sage Therapeutics Inc (NASDAQ: SAGE) was $10.81 for the day, down -1.64% from the previous closing price of $10.99. In other words, the price has decreased by -$1.64 from its previous closing price. On the day, 0.82 million shares were traded. SAGE stock price reached its highest trading level at $11.25 during the session, while it also had its lowest trading level at $10.67.
Ratios:
Our analysis of SAGE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.22 and its Current Ratio is at 12.22. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on July 25, 2024, Downgraded its rating to Neutral and sets its target price to $12 from $18 previously.
On May 29, 2024, Robert W. Baird started tracking the stock assigning a Neutral rating and target price of $15.
On May 29, 2024, Citigroup started tracking the stock assigning a Sell rating and target price of $8.Citigroup initiated its Sell rating on May 29, 2024, with a $8 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 09 ’23 when Barrett Elizabeth bought 2,000 shares for $18.64 per share. The transaction valued at 37,279 led to the insider holds 3,000 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SAGE now has a Market Capitalization of 650567424 and an Enterprise Value of -63139244. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.14 while its Price-to-Book (P/B) ratio in mrq is 0.92. Its current Enterprise Value per Revenue stands at -0.693 whereas that against EBITDA is 0.124.
Stock Price History:
Over the past 52 weeks, SAGE has reached a high of $37.17, while it has fallen to a 52-week low of $9.73. The 50-Day Moving Average of the stock is -4.57%, while the 200-Day Moving Average is calculated to be -39.30%.
Shares Statistics:
SAGE traded an average of 1.22M shares per day over the past three months and 1096120 shares per day over the past ten days. A total of 60.04M shares are outstanding, with a floating share count of 49.49M. Insiders hold about 17.76% of the company’s shares, while institutions hold 91.55% stake in the company. Shares short for SAGE as of 1721001600 were 5570687 with a Short Ratio of 4.58, compared to 1718323200 on 7798079. Therefore, it implies a Short% of Shares Outstanding of 5570687 and a Short% of Float of 10.5100006.
